F M Cowan1, A Copas, A M Johnson, R Ashley, L Corey, A Mindel. 1. Department of Sexually Transmitted Diseases, Royal Free and University College Medical School, University College London, UK. frances@uz-ucsf.co.zw
Abstract
OBJECTIVES: To examine the factors associated with antibodies to herpes simplex virus type 1 (HSV-1). DESIGN: Cross sectional study with HSV-1 antibody testing performed by University of Washington western blot assay. SETTING: Central London STD clinic (1990-1) and central London blood donation centre (1992). PARTICIPANTS: Representative sample of 869 new and rebooked GUM clinic attenders and 1494 consecutive blood donors. RESULTS: The prevalence of HSV-1 antibody among clinic attenders was 60.4% (95% CI 57.0 to 63.7) and among donors was 46.1% (95% CI 43.5 to 48.7). HSV-1 antibody was independently associated with increasing age in both populations (p<0.001). Among clinic attenders, HSV-1 was less common among heterosexual men than women and homosexual men (p<0.005), and was more common among black people (p=0.001) and those of lower socioeconomic status (p=0.05). Among blood donors, being single rather than married was independently associated with HSV-1 infection (p=0.03). Early age at first intercourse was strongly associated with presence of HSV-1 in both populations. The adjusted odds of HSV-1 among GUM clinic attenders was 0.37 (95% CI 0.21 to 0.65) for someone aged 20 at first intercourse compared with someone aged <or=15. Among blood donors, those aged 20 had an adjusted odds of 0.64 (95% CI 0.39 to 1.05) compared with someone aged 15. HSV-1 was not associated with increasing number of lifetime partners after adjustment for other factors. CONCLUSIONS: Genital herpes due to HSV-1 antibody is increasing in the United Kingdom, particularly among young people. In this study we found that HSV-1 was strongly associated with early age of first sexual intercourse, which may reflect the sexual practices of people initiating sex in this age group.
OBJECTIVES: To examine the factors associated with antibodies to herpes simplex virus type 1 (HSV-1). DESIGN: Cross sectional study with HSV-1 antibody testing performed by University of Washington western blot assay. SETTING: Central London STD clinic (1990-1) and central London blood donation centre (1992). PARTICIPANTS: Representative sample of 869 new and rebooked GUM clinic attenders and 1494 consecutive blood donors. RESULTS: The prevalence of HSV-1 antibody among clinic attenders was 60.4% (95% CI 57.0 to 63.7) and among donors was 46.1% (95% CI 43.5 to 48.7). HSV-1 antibody was independently associated with increasing age in both populations (p<0.001). Among clinic attenders, HSV-1 was less common among heterosexual men than women and homosexual men (p<0.005), and was more common among black people (p=0.001) and those of lower socioeconomic status (p=0.05). Among blood donors, being single rather than married was independently associated with HSV-1 infection (p=0.03). Early age at first intercourse was strongly associated with presence of HSV-1 in both populations. The adjusted odds of HSV-1 among GUM clinic attenders was 0.37 (95% CI 0.21 to 0.65) for someone aged 20 at first intercourse compared with someone aged <or=15. Among blood donors, those aged 20 had an adjusted odds of 0.64 (95% CI 0.39 to 1.05) compared with someone aged 15. HSV-1 was not associated with increasing number of lifetime partners after adjustment for other factors. CONCLUSIONS: Genital herpes due to HSV-1 antibody is increasing in the United Kingdom, particularly among young people. In this study we found that HSV-1 was strongly associated with early age of first sexual intercourse, which may reflect the sexual practices of people initiating sex in this age group.
Authors: K Wellings; K Nanchahal; W Macdowall; S McManus; B Erens; C H Mercer; A M Johnson; A J Copas; C Korovessis; K A Fenton; J Field Journal: Lancet Date: 2001-12-01 Impact factor: 79.321
Authors: L Corey; A G Langenberg; R Ashley; R E Sekulovich; A E Izu; J M Douglas; H H Handsfield; T Warren; L Marr; S Tyring; R DiCarlo; A A Adimora; P Leone; C L Dekker; R L Burke; W P Leong; S E Straus Journal: JAMA Date: 1999-07-28 Impact factor: 56.272
Authors: Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey Journal: N Engl J Med Date: 1997-08-21 Impact factor: 91.245
Authors: Neha Garg; Dylan Boyle; Arlo Randall; Andy Teng; Jozelyn Pablo; Xiaowu Liang; David Camerini; Abraham P Lee Journal: Lab Chip Date: 2019-04-23 Impact factor: 6.799